Literature DB >> 30201684

H19 lncRNA Promotes Skeletal Muscle Insulin Sensitivity in Part by Targeting AMPK.

Tingting Geng1,2, Ya Liu1,3, Yetao Xu1,4, Ying Jiang5, Na Zhang6, Zhangsheng Wang1,7, Gordon G Carmichael6, Hugh S Taylor1, Da Li8,9, Yingqun Huang8.   

Abstract

Skeletal muscle plays a pivotal role in regulating systemic glucose homeostasis in part through the conserved cellular energy sensor AMPK. AMPK activation increases glucose uptake, lipid oxidation, and mitochondrial biogenesis, leading to enhanced muscle insulin sensitivity and whole-body energy metabolism. Here we show that the muscle-enriched H19 long noncoding RNA (lncRNA) acts to enhance muscle insulin sensitivity, at least in part, by activating AMPK. We identify the atypical dual-specificity phosphatase DUSP27/DUPD1 as a potentially important downstream effector of H19. We show that DUSP27, which is highly expressed in muscle with previously unknown physiological function, interacts with and activates AMPK in muscle cells. Consistent with decreased H19 expression in the muscle of insulin-resistant human subjects and rodents, mice with genetic H19 ablation exhibit muscle insulin resistance. Furthermore, a high-fat diet downregulates muscle H19 via both posttranscriptional and epigenetic mechanisms. Our results uncover an evolutionarily conserved, highly expressed lncRNA as an important regulator of muscle insulin sensitivity.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30201684      PMCID: PMC6198334          DOI: 10.2337/db18-0370

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  47 in total

1.  Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element.

Authors:  M A Ripoche; C Kress; F Poirier; L Dandolo
Journal:  Genes Dev       Date:  1997-06-15       Impact factor: 11.361

2.  A Long Non-coding RNA, lncLGR, Regulates Hepatic Glucokinase Expression and Glycogen Storage during Fasting.

Authors:  Xiangbo Ruan; Ping Li; Andrew Cangelosi; Ling Yang; Haiming Cao
Journal:  Cell Rep       Date:  2016-02-18       Impact factor: 9.423

Review 3.  AMPK: positive and negative regulation, and its role in whole-body energy homeostasis.

Authors:  D Grahame Hardie
Journal:  Curr Opin Cell Biol       Date:  2014-09-26       Impact factor: 8.382

Review 4.  Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive.

Authors:  Yevgeniya Dynkevich; Kristina I Rother; Ian Whitford; Sana Qureshi; Sneha Galiveeti; Alessandra L Szulc; Ann Danoff; Tracy L Breen; Nargess Kaviani; Michael H Shanik; Derek Leroith; Riccardo Vigneri; Christian A Koch; Jesse Roth
Journal:  Endocr Rev       Date:  2013-05-13       Impact factor: 19.871

Review 5.  Age-related changes in AMPK activation: Role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways.

Authors:  Antero Salminen; Kai Kaarniranta; Anu Kauppinen
Journal:  Ageing Res Rev       Date:  2016-04-06       Impact factor: 10.895

6.  Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.

Authors:  L Yan; J Zhou; Y Gao; S Ghazal; L Lu; S Bellone; Y Yang; N Liu; X Zhao; A D Santin; H Taylor; Y Huang
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

7.  The Lin28/let-7 axis regulates glucose metabolism.

Authors:  Hao Zhu; Ng Shyh-Chang; Ayellet V Segrè; Gen Shinoda; Samar P Shah; William S Einhorn; Ayumu Takeuchi; Jesse M Engreitz; John P Hagan; Michael G Kharas; Achia Urbach; James E Thornton; Robinson Triboulet; Richard I Gregory; David Altshuler; George Q Daley
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

8.  Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice.

Authors:  Michael J Jurczak; Ann-Hwee Lee; Francois R Jornayvaz; Hui-Young Lee; Andreas L Birkenfeld; Blas A Guigni; Mario Kahn; Varman T Samuel; Laurie H Glimcher; Gerald I Shulman
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

9.  The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells.

Authors:  Yuan Gao; Fuju Wu; Jichun Zhou; Lei Yan; Michael J Jurczak; Hui-Young Lee; Lihua Yang; Martin Mueller; Xiao-Bo Zhou; Luisa Dandolo; Julia Szendroedi; Michael Roden; Clare Flannery; Hugh Taylor; Gordon G Carmichael; Gerald I Shulman; Yingqun Huang
Journal:  Nucleic Acids Res       Date:  2014-11-15       Impact factor: 16.971

10.  H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase.

Authors:  Jichun Zhou; Lihua Yang; Tianyu Zhong; Martin Mueller; Yi Men; Na Zhang; Juanke Xie; Karolyn Giang; Hunter Chung; Xueguang Sun; Lingeng Lu; Gordon G Carmichael; Hugh S Taylor; Yingqun Huang
Journal:  Nat Commun       Date:  2015-12-21       Impact factor: 14.919

View more
  26 in total

Review 1.  Role of epigenomic mechanisms in the onset and management of insulin resistance.

Authors:  Andrea G Izquierdo; Ana B Crujeiras
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 2.  Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

Authors:  Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

3.  High-resolution genome-wide expression analysis of single myofibers using SMART-Seq.

Authors:  Darren M Blackburn; Felicia Lazure; Aldo H Corchado; Theodore J Perkins; Hamed S Najafabadi; Vahab D Soleimani
Journal:  J Biol Chem       Date:  2019-11-21       Impact factor: 5.157

4.  Relationship between the Levels of lncRNA H19 in Plasma and Different Adipose Tissue Depots with Patients' Response to Bariatric Surgery.

Authors:  Marina S Artemyeva; Ludmila B Vasileva; Yi Ma; Kirill A Kondratov; Anton V Fedorov; Anna A Kostareva; Sofia E Lapshina; Anna D Anopova; Nikolai P Likhonosov; Alexander E Neymark; Alina Yu Babenko; Evgeny V Shlyakhto
Journal:  Life (Basel)       Date:  2022-04-25

5.  A novel regulatory mechanism network mediated by lncRNA TUG1 that induces the impairment of spiral artery remodeling in preeclampsia.

Authors:  Yetao Xu; Dan Wu; Bingqing Hui; Lijun Shu; Xiaotong Tang; Cong Wang; Jiaheng Xie; Yin Yin; Matthew Sagnelli; Nana Yang; Ziyan Jiang; Yuanyuan Zhang; Lizhou Sun
Journal:  Mol Ther       Date:  2022-02-04       Impact factor: 12.910

6.  RNA sequencing reveals potential interacting networks between the altered transcriptome and ncRNome in the skeletal muscle of diabetic mice.

Authors:  Devesh Kesharwani; Amit Kumar; Mukta Poojary; Vinod Scaria; Malabika Datta
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

Review 7.  Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.

Authors:  B Alipoor; S Nikouei; F Rezaeinejad; S-N Malakooti-Dehkordi; Z Sabati; H Ghasemi
Journal:  J Endocrinol Invest       Date:  2021-04-01       Impact factor: 4.256

8.  Association of Genetic Variants in IGF2-Related Genes With Risk of Metabolic Syndrome in the Chinese Han Population.

Authors:  Weiwei Gui; Julong Liang; Xihua Lin; Nanjing Shi; Yiyi Zhu; Bowen Tan; Hong Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-20       Impact factor: 5.555

Review 9.  Regulation of Glucose and Lipid Metabolism by Long Non-coding RNAs: Facts and Research Progress.

Authors:  Tie-Ning Zhang; Wei Wang; Ni Yang; Xin-Mei Huang; Chun-Feng Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-16       Impact factor: 5.555

10.  H19/TET1 axis promotes TGF-β signaling linked to endothelial-to-mesenchymal transition.

Authors:  Tiefeng Cao; Ying Jiang; Da Li; Xiaoli Sun; Yuanyuan Zhang; Lingfeng Qin; George Tellides; Hugh S Taylor; Yingqun Huang
Journal:  FASEB J       Date:  2020-05-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.